Simultaneous Chronic Lymphocytic Leukemia and Hairy Cell Leukemia: a Sporadic Event? A Semantic Point of View. by luiza akria, celia suriu, ytzkak cohen, judith chezar, andrei braester

“…The occurrence of second neoplasm in HCL patients is well-known, especially non-Hodgkin's lymphomas. In the last 10 years we diagnosed in our hemato-oncologic clinic 22 cases of HCL, 4 of them (18 % of all cases of HCL diagnosed during this period) with concomitant both diseases. …”
Get full text

Epstein-Barr Virus (EBV) detection and typing by PCR: a contribution to diagnostic screening of EBV-positive Burkitt's lymphoma by Seuánez Héctor N, Bacchi Carlos E, Klumb Claudete, Felisbino Fabricio E, de Oliveira Deilson, Stefanoff Claudio, White Lídia, Hassan Rocío, Zalcberg Ilana R

“…We performed a systematic comparison between RISH and PCR for EBV detection, in a group of childhood B-cell Non-Hodgkin lymphomas (NHL), aiming to validate PCR as a first, rapid method for the diagnosis of EBV-associated B-cell NHL.…”
Get full text

Anaplastic large cell lymphoma presenting as a soft tissue mass – A case report by Siti-Aishah M.A., Salwati S, Idrus M., Rahimah R., Salmi A., Leong C.F., Sharifah N.A

“…Anaplastic large cell lymphoma (ALCL) is a rare tumour, accounting for approximately 3% of adult non-Hodgkin lymphomas.1 Primary systemic ALCL frequently involves both lymph nodes and extranodal sites. …”
Get full text

Large-Scale Proteomic Analysis of Follicular Lymphoma Reveals Extensive Remodeling of Cell Adhesion Pathway and Identifies Hub Proteins Related to the Lymphomagenesis by Kamila Duś-Szachniewicz, Grzegorz Rymkiewicz, Anil Kumar Agrawal, Paweł Kołodziej, Jacek R. Wiśniewski

“…Follicular lymphoma (FL) represents the major subtype of indolent B-cell non-Hodgkin lymphomas (B-NHLs) and results from the malignant transformation of mature B-cells in lymphoid organs. …”
Get full text

Extranodal Natural Killer/T-cell Lymphoma, Nasal Type: Diagnosis and Treatment by Jaap A. van Doesum, Anne G. H. Niezink, Gerwin A. Huls, Max Beijert, Arjan Diepstra, Tom van Meerten

“…By contrast, incidence is low in the United States and Europe, where extranodal natural killer/T-cell lymphoma represents only 0.2%-0.4% of all newly diagnosed non-Hodgkin lymphomas. At diagnosis, it is important to test for EBV DNA in plasma by polymerase chain reaction and to carry out positron emission tomography/computer tomography and magnetic resonance imaging of the nasopharynx. …”
Get full text

Important Diagnostic Clues for Diagnosing Splenic Marginal Zone Lymphoma in Absence of Splenic Histology by Anisha Mohanpuria, Vijay Kumar, Pooja Suteri, Sadhna Marwah, Abhay Shankar Nigam

“…Splenic Marginal Zone Lymphoma (SMZL) is a rare B-cell neoplasm comprising less than 2% of non-Hodgkin lymphomas. We hereby report a case of SMZL in a 66-year-old female who presented with fever and massive splenomegaly. …”
Get full text

Artificial Intelligence Analysis and Reverse Engineering of Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using Gene Expression Data by Joaquim Carreras, Yara Yukie Kikuti, Masashi Miyaoka, Saya Miyahara, Giovanna Roncador, Rifat Hamoudi, Naoya Nakamura

“…Diffuse large B-cell lymphoma is one of the most frequent mature B-cell hematological neoplasms and non-Hodgkin lymphomas. Despite advances in diagnosis and treatment, clinical evolution is unfavorable in a subset of patients. …”
Get full text

Bruton’s Tyrosine Kinase Inhibitor Zanubrutinib Effectively Modulates Cancer Resistance by Inhibiting Anthracycline Metabolism and Efflux by Lucie Čermáková, Jakub Hofman, Lenka Laštovičková, Lucie Havlíčková, Ivona Špringrová, Eva Novotná, Vladimír Wsól

“…Zanubrutinib (ZAN) is a Bruton’s tyrosine kinase inhibitor recently approved for the treatment of some non-Hodgkin lymphomas. In clinical trials, ZAN is often combined with standard anthracycline (ANT) chemotherapy. …”
Get full text

Blood Stem Cell Collection: Factors Influencing the Recovery of Granulocyte-Macrophage Colony Forming Cells by Kevin Imrie, A. Keith Stewart, R. Michael Crump, H. Miles Prince, Kathy Trip, Armand Keating

“…Malignant diagnoses were: non-Hodgkins lymphoma (NHL) in 35%, multiple myeloma in 31%, breast cancer in 26%, and Hodgkin's disease in 8%. …”
Get full text

DISTRIBUTION OF EPSTEIN - BARR VIRUS AMONG WOMEN OF REPRODUCTIVE AGE AND CHILDREN UP TO 1 YEAR IN THE VARNA REGION by Tsvetelina Kostadinova, Liliya Ivanova, Denitsa Tsaneva, Neli Ermenlieva, Zhivka Stoykova, Gabriela Tsankova

“…Also, the virus is associated with the development of Hodgkin's and non-Hodgkin's lymphomas and nasopharyngeal carcinoma. The evidence of its role in neonatal pathology is contradictory and not well known. …”
Get full text

Quantitative evaluation of interim positron emission tomography in peripheral T-cell lymphoma by Lars Kurch, Ulrich Dührsen, Andreas Hüttmann, Thomas W. Georgi, Osama Sabri, Regine Kluge, Dirk Hasenclever

“…Methods Interim scans from 43 patients with anaplastic lymphoma kinase-negative PTCL from the ‘Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas’ trial were re-analyzed by qPET (relating residual lymphoma-related uptake to liver uptake) and ∆SUVmax (relating interim scan to baseline scan). …”
Get full text

First Case Report of Primary Testicular Diffuse Large B-Cell Lymphoma from the Western Region of Saudi Arabia by Abdulkader Albasri, Mohammed A. Elkablawy, Ahmed Abdelbadie, Akbar S. Hussainy, Abdelaziz R. Aljohani, Abdelaziz R. Aljohani

“…Primary testicular lymphoma (PTL) represents 1-2% of all types of non-Hodgkin lymphomas (NHLs) and 1-10% of testicular neoplasms. …”
Get full text

Biochemical, Enzymatic, and Computational Characterization of Recurrent Somatic Mutations of the Human Protein Tyrosine Phosphatase PTP1B in Primary Mediastinal B Cell Lymphoma by Rongxing Liu, Yujie Sun, Jérémy Berthelet, Linh-Chi Bui, Ximing Xu, Mireille Viguier, Jean-Marie Dupret, Frédérique Deshayes, Fernando Rodrigues Lima

“…Notably, recurrent somatic mutations and splice variants of PTP1B were identified in human B cell and Hodgkin lymphomas. In this work, we analyzed the molecular and functional levels of three PTP1B mutations identified in primary mediastinal B cell lymphoma (PMBCL) patients and located in the WPD-loop (V184D), P-loop (R221G), and Q-loop (G259V). …”
Get full text

Rapid response in relapsed follicular lymphoma with massive chylous ascites to anti-CD19 CAR T therapy using Piggy Bac: A case report by Yan Zhang, Zhicai Lin, Faliang Zhang, Xiuxiu Chen, Yaping Yang, Xin Fu, Zhong Li, Zhong Li, Yan Sun, Qijun Qian, Qijun Qian

“…CD19-directed chimeric antigen receptor (CAR) T cell therapy has been shown to achieve a considerably durable response in patients with refractory or relapsed B cell non-Hodgkin lymphomas, as seen from the results of Zuma-1, Zuma-5, and other clinical trials. …”
Get full text

Predisposing Factors, Clinical Picture, and Outcome of B-Cell Non-Hodgkin’s Lymphoma in Sjögren’s Syndrome by Ioanna E. Stergiou, Andreas V. Goules, Michael Voulgarelis, Athanasios G. Tzioufas

“…Thus, most pSS-related lymphomas are B-cell non-Hodgkin lymphomas (NHLs), with mucosa-associated lymphoid tissue (MALT) lymphomas predominating, followed by diffuse large B-cell lymphomas (DLBCLs) and nodal marginal zone lymphomas (NMZLs). …”
Get full text

Blastoid mantle cell lymphoma involving skin and orbit with hypercalcemia: A case report and literature review by Juan Li, Han Ma, Xiuzhen Tong, Chang Su, Dong Zheng, Mei Chen, Chun Lu

“…Mantel cell lymphoma is one of the small B-cell non-Hodgkin's lymphomas and usually involves lymph nodes, bone marrow, spleen, liver, gastrointestinal tract, and Waldeyer's ring, but rarely skin and orbit. …”
Get full text

CCL2 rs1024611Gene Polymorphism in Philadelphia-Negative Myeloproliferative Neoplasms by Hossam Hodeib, Dina Abd EL Hai, Mohamed A Tawfik, Alzahraa A. Allam, Amal Selim, Abdallah Ahmed Elsawy, Amira Youssef

“…The CCL2 gene is overexpressed by non-Hodgkin lymphomas and multiple solid tumors. Aim of the study: to evaluate the possible association of CCL2 rs1024611 SNP and its expression level and the risk of developing Philadelphia-negative MPNs. …”
Get full text

Novel synthesizing method of pH-dependent doxorubicin-loaded anti-CD22-labelled drug delivery nanosystem by Sun M, Wang J, Lu Q, Xia G, Zhang Y, Song L, Fang Y

“…Therefore, it was concluded that a coloaded antibody and chemo­therapeutic drug with magnetic nanoparticles might be an efficient targeted treatment strategy for non-Hodgkin’s lymphoma.Keywords: doxorubicin, anti-CD22 antibody, drug delivery system, target selection, non-Hodgkin lymphoma…”
Get full text

First Case Report of Primary Testicular Diffuse Large B-Cell Lymphoma from the Western Region of Saudi Arabia by Abdulkader Albasri, Mohammed A. Elkablawy, Ahmed Abdelbadie, Akbar S. Hussainy, Abdelaziz R. Aljohani

“…Primary testicular lymphoma (PTL) represents 1-2% of all types of non-Hodgkin lymphomas (NHLs) and 1-10% of testicular neoplasms. …”
Get full text

Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis by Su, I-hsin, Talukder, Asoke K., Nojima, Takuya, Doglioni, Claudio, Kitamura, Daisuke, Toellner, Kai-M, Casola, Stefano, Caganova, Marieta, Carrisi, Chiara, Varano, Gabriele, Mainoldi, Federica, Zanardi, Federica, Germain, Pierre-Luc, George, Laura, Alberghini, Federica, Ferrarini, Luca, Ponzoni, Maurilio, Testa, Giuseppe

“…The histone H3 lysine 27 methyltransferase enhancer of zeste homolog 2 (EZH2) is highly expressed in GC B cells and is often constitutively activated in GC-derived non-Hodgkin lymphomas (NHLs). The function of EZH2 in GC B cells remains largely unknown. …”
Get full text
Get full text